Sino-European Science and Technology Collaboration on Personalized Medicine: Overview, Trends and Future Perspectives

Abstract

Aim: Personalized medicine (PM) is revolutionizing biomedical and clinical research while improving the ways healthcare is delivered. The EU is at the forefront of science and innovation in this field, increasing collaborations worldwide. This paper aims to assess the status of recent collaborations between Europe and China in PM-related science, technology and funded research. Methods: We analyze scientific literature, patents and funding programs, respectively. Results: PM is a scientific and industrial priority in both geographical areas, but current levels of collaboration are suboptimal. To increase these levels, policy makers should promote cooperation between researchers, innovators, industries, regulators, funding agencies and healthcare systems, while providing a forum to exchange best practices, define common guidelines for PM implementation and promote public–private partnerships.

Keywords::

• bibliometric
• China
• collaboration
• Europe
• ICPerMed
• patentometric
• patents
• personalized medicine
• publications
• Sino-EU PerMed
• technology

Supplementary data

To view the supplementary data that accompany this paper please visit the journal website at: www.tandfonline.com/doi/suppl/10.2217/pme-2021-0030

Acknowledgments

The authors thank J Egar, Canadian Institute of Health Research – Institute of Genetics, for help editing the manuscript. The authors would also like to thank Y Xu (X Yong), Guangzhou Institutes of Biomedicine and Health (GIBH), for help editing the manuscript.

Financial & competing interests disclosure

The Coordination and Support Action Sino-EU PerMed has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no. 874556. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Additional information

Funding

The Coordination and Support Action Sino-EU PerMed has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no. 874556. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.